Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

114 results about "Lactobacillus strain" patented technology

Lactobacillus GG is a strain of good-for-you bacteria that was first discovered in 1985. Now, over 30 years later, it has been the subject of over 1,000 clinical studies, making it the number one most studied probiotic strain. 1†† But what is it about this beneficial bacteria strain that keeps scientists...

Probiotic composition for preventing and / or improving oral health as well as derivative product and application thereof

The invention provides a probiotic composition for preventing and / or improving oral health as well as a derivative product and application thereof, and belongs to the technical field of functional microorganisms. The invention provides a probiotic composition for preventing and / or improving oral health. The probiotic composition comprises a plant lactobacillus strain SLB01, a plant lactobacillus strain A21094 and a lactobacillus rhamnosus strain A25003. After the bacterial strain SLB01, the bacterial strain A21094 and the bacterial strain A25003 are compounded, the supernate and thalli of the bacterial strain have a good antibacterial effect on fusobacterium nucleatum, porphyromonas gingivalis, staphylococcus aureus, helicobacter pylori and various streptococcus, and have a good agglutination effect and an effect of inhibiting inflammatory response. As a novel oral health intervention means, the probiotic composition can be used for preparing toothpaste, oral liquid, oral lozenges and other products, and has potential benefits in the aspects of preventing or treating oral inflammation, maintaining oral health and the like.
Owner:AIAGE LIFE SCI CORP LTD

Isolated lactobacilliaceae strains, compositions containing the same and uses thereof

The present disclosure provides isolated Lactobacillus strains, compositions comprising the same, and uses thereof, which can be used to promote growth and development, enhance immunity, or promote intestinal health, etc.
Owner:MOON (GUANGZHOU) BIOTECH CO LTD

Lactobacillus plantarum MRS1026.3, method and application

The invention belongs to the technical field of microorganisms, and particularly relates to lactobacillus plantarum, a method and application. The invention provides a strain of Lactobacillus plantarum MRS1026.3, and the preservation number of the Lactobacillus plantarum MRS1026.3 is CGMCC (China General Microbiological Culture Collection Center) No.34168. The invention further provides a preparation method of the Lactobacillus plantarum MRS1026.3. The lactobacillus plantarum MRS1026.3 has the best tolerance of 72.38% and the acid resistance of 49.5% under the cholate concentration of 0.1%, is good in acid resistance, has oxidation resistance and can degrade cholesterol, but the surface hydrophobicity and the self-aggregation capacity of the lactobacillus plantarum MRS1026.3 are poor.
Owner:SHENZHEN UNIV

Lactic acid bacteria and application thereof

The invention discloses a lactic acid bacterium and application thereof, the lactic acid bacterium is named as Lactiplantibacillus plantarum SCZH-7 and is preserved in the China Center for Type Culture Collection (CCTCC), the preservation number is CCTCC NO: M 2024523, and the preservation date is March 18, 2024. The Lactobacillus plantarum SCZH-7 disclosed by the invention has a relatively good inhibition effect on Gram-positive and Gram-negative pathogenic bacteria, can enrich the preservation library of Lactobacillus strains, and is widely applied to dairy products, cosmetics, fermented foods and the like.
Owner:SICHUAN AGRI UNIV

Lactobacillus salivarius strains and uses thereof

The present invention provides a novel isolated strain of the microorganism Lactobacillus salivarius, compositions comprising the same, and their use in the prevention and / or treatment of infertility and infectious diseases, as well as in non-therapeutic applications.
Owner:CHEMO RES SL

Production process of compound lactobacillus fermented chili sauce and method for preparing sour soup

The invention belongs to the field of food production and processing, and requests to protect a production process of compound lactobacillus fermented chilli sauce and a method for preparing sour soup, fresh red chilli is used as a main raw material, and the chilli sauce raw material is prepared by cleaning, selecting, crushing, preheating, grinding, pulping, adding or not adding edible glacial acetic acid or citric acid, concentrating, sterilizing and aseptically filling; performing blending and temporary storage, pre-sterilization, cooling, compound lactobacillus strain pre-dissolution, feeding, stirring, fermentation, re-sterilization and sterile filling to obtain the compound lactobacillus fermented chilli sauce, and blending the compound lactobacillus fermented chilli sauce with fermented tomato sauce, edible oil and the like to obtain the sour soup. Industrial compound lactic acid bacteria are adopted, various organic acids, amino acids and the like are generated through metabolism, the fermented chili sauce is endowed with unique sour and fragrant flavor, the taste is mellower, and the fermentation process is controllable and stable; meanwhile, the prepared fermented chilli sauce is innovatively applied to sour soup products, the standardization degree of the products is high, and the production efficiency is improved.
Owner:COFCO TUNHE TOMATO CO LTD

Lactobacillus mucilaginosus for producing gamma-aminobutyric acid and application thereof

The invention discloses lactobacillus mucus for producing gamma-aminobutyric acid and application of the lactobacillus mucus, and provides the lactobacillus mucus for producing gamma-aminobutyric acid with high yield, the lactobacillus mucus is named as lactobacillus mucus B41, the preservation number is CCTCC NO: M 20242081, the preservation unit is China Center for Type Culture Collection, the preservation number is CCTCC NO: M 20242081, the preservation number is CCTCC NO: M 20242081, the preservation number is CCTCC NO: M 20242081, the preservation number is CCTCC NO: M 20242081, and the preservation number is CCTCC NO: M 20242081. The preservation address is Wuhan University Campus, Wuchang District, Wuchang District, Hubei Province, No. 299. The strain can produce gamma-aminobutyric acid at high yield, and fermented milk rich in gamma-aminobutyric acid can be produced by using the fermented lactobacillus mucus.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Probiotic composition for inhibiting helicobacter pylori and probiotic agent and application thereof

The invention provides a probiotic composition for inhibiting helicobacter pylori as well as a probiotic agent and application thereof, and belongs to the technical field of probiotic functional products. The probiotic composition is prepared from the following components in parts by weight: 0.05 to 2 parts of a pediococcus pentosaceus strain A21358, 0.01 to 1.5 parts of a plant lactobacillus strain A21136, 0.05 to 1.5 parts of a lactobacillus rhamnosus strain A21149 and 0.03 to 1.2 parts of a lactobacillus reuteri strain A21325. The probiotic agent comprises the probiotic composition, resistant dextrin, xylooligosaccharide, erythritol, inulin, fructo-oligosaccharide, hericium erinaceus powder, fucoidin and at least one fruit powder selected from grape powder, passion fruit powder and kiwi fruit powder, wherein the specific weight parts of the resistant dextrin, the xylooligosaccharide, the erythritol, the inulin, the fructo-oligosaccharide, the hericium erinaceus powder, the fucoidin and the at least one fruit powder are selected from grape powder, passion fruit powder and kiwi fruit powder. The probiotic agent has the effect of inhibiting helicobacter pylori, and a new thought is provided for clinical related auxiliary treatment of helicobacter pylori infection.
Owner:SICHUAN AISHENG LIFE TECHNOLOGY CO LTD +2

Phytobacterium plantarum JN-7, bacterium powder, preparation method, probiotic composition and application thereof

The invention relates to a plant lactobacillus JN-7, bacterial powder, a preparation method, a probiotic composition and application thereof. According to the application, a new plant lactobacillus strain is obtained through screening, the new plant lactobacillus strain is named as plant lactobacillus JN-7, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) No.30605. Basic characteristic analysis (growth curve, acid resistance, cholate resistance and gastrointestinal fluid resistance), safety evaluation (antibiotic sensitivity, hemolysis capability, toxin production capability and cytotoxicity), adhesiveness evaluation, anti-inflammatory action evaluation, production performance evaluation (fermentation yield and freeze-drying yield) and stability test (accelerated storage stability test) of the strain are carried out; it is found that the plant lactobacillus JN-7 is a safe strain and has excellent production performance, high stability and an anti-inflammatory effect. The bacterial powder produced by the bacterial strain can keep stable and active for a long time.
Owner:ADM (SHANGHAI) MANAGEMENT CO LTD

Application of lactobacillus plantarum strain A21337 in preparation of product for resisting anxiety and improving memory and concentration

The invention provides an application of a lactobacillus plantarum strain A21337 in preparation of a product for resisting anxiety and improving memory and concentration, and belongs to the technical field of biological medicines. Animal experiments show that the plant lactobacillus strain A21337 has the effects of resisting anxiety, resisting depression, improving cognitive impairment function and improving memory concentration, and a new means is provided for preventing and / or treating nerve diseases related to anxiety disorder, depression and cognitive impairment.
Owner:GUANGXI ACAD OF SCI +1

Phytobacterium plantarum strain A21337 with functions of inhibiting bacteria and secreting 5-hydroxytryptamine as well as probiotic agent and application thereof

The invention provides a lactobacillus plantarum strain A21337 with the functions of inhibiting bacteria and secreting 5-hydroxytryptamine, a probiotic agent of the lactobacillus plantarum strain A21337 and application of the lactobacillus plantarum strain A21337, and belongs to the technical field of functional microorganisms. The invention provides application of phytobacterium plantarum or a microbial agent containing the phytobacterium plantarum in preparation of a product resisting pathogenic bacteria and / or rich in 5-hydroxytryptamine. According to the invention, a plant lactobacillus strain A21337 is separated from intestinal feces of healthy 100-year old people in Guangxi province, has the characteristics of secreting 5-hydroxytryptamine and inhibiting pathogenic bacteria, and has good tolerance to gastrointestinal fluid. Therefore, the strain A21337 or the probiotic agent containing the strain A21337 provides a new means for preparing a product which is resistant to pathogenic bacteria and / or rich in 5-hydroxytryptamine.
Owner:GUANGXI ACAD OF SCI +1

Lactobacillus fermentum strain from egyptian cheese and its application in inhibiting bacteria and anti-salmonella infection

The application discloses a plant lactobacillus strain and application thereof, and belongs to the technical field of microorganisms. The preservation number of the strain is CGMCC No. 33864. The strain has good tolerance to gastrointestinal juice and bile salts and has no hemolytic activity. Concentrated cell-free supernatant prepared from the strain can inhibit salmonella, including inhibiting the growth of salmonella, killing bacteria, inhibiting or removing biofilm. Animal experiments show that the strain and the concentrated cell-free supernatant thereof can prevent salmonella infection, alleviate weight loss caused by infection, maintain intestinal barrier integrity, reduce the level of pro-inflammatory factors, alleviate tissue damage, improve the expression of colon tight junction proteins and mucin, promote the generation of short-chain fatty acids, and restore the intestinal flora structure. The application further provides a microbial preparation containing the strain and / or the concentrated cell-free supernatant thereof. The strain and the microbial preparation can be used for preparing products for resisting salmonella, preventing salmonella infection or improving intestinal health.
Owner:SOUTHWEST UNIV

Strains of lactic acid bacteria and uses thereof in packing water for improving mozzarella flavoring

PCT designated stage expiredWO2025132628A3Milk preparationBacteriaBiotechnologyGenus Lactococcus
The present invention belongs to the field of food products, in particular fresh mozzarella, and provides packing water suitable for directly acidified fresh mozzarella comprising at least one lactic acid bacterium (LAB), preferably wherein the at least one LAB strain is selected from a Lactobacillus strain, a Lactiplantibacillus strain, a Lacticaseibacillus strain or a Lactococcus strain. The invention further provides LAB suitable for being comprised in the packing water of the present invention and methods for producing packaged fresh mozzarella using the packing water and LAB of the present invention.
Owner:CHR HANSEN AS

Compositions comprising lactobacillus strains, and methods of treating osteoarthritis and osteoarthritis co-morbidities

PCT designated stage expiredWO2025043142A1Skeletal disorderUnknown materialsJoint painArthritis
Disclosed herein are compositions comprising or consisting of Lactobacillus acidophilus and one or more prebiotics. Also disclosed herein are methods for treating osteoarthritis, inhibiting or preventing cartilage degeneration, and reducing or inhibiting pain-associated depression in subjects with joint pain with compositions comprising or consisting of Lactobacillus acidophilus and one or more prebiotics.
Owner:THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS +1

Lactobacillus leavening growth-promoting strain KUST4216 for shortening food fermentation time and producing p-cresol at high yield and application of lactobacillus leavening growth-promoting strain KUST4216

The invention discloses a leavening dough growth-promoting lactobacillus strain KUST4216 for shortening food fermentation time and producing p-cresol at high yield and application of the leavening dough growth-promoting lactobacillus strain KUST4216. The strain is classified and named as Levibacillus zyma KUST4216; the preservation number of the strain is GDMCC NO: 65660. The content of p-cresol in fermentation liquor is larger than or equal to 5 mg / kg after acid bamboo shoots are fermented by the strain for 7 days; after the brine is fermented for 4 to 5 days, the content of p-cresol is 15.5 to 22 mg / kg; the content of p-cresol in the fish dices fermented for 5 days is 5-6 mg / kg, the fermentation effect reaches the content of p-cresol obtained after fermentation of an existing natural fermentation method for 1 month, and the fermentation speed is effectively shortened.
Owner:KUNMING UNIV OF SCI & TECH

Non-target intestinal tract phytobacterium lactis strain capable of improving insecticidal activity of Cry protein and application of non-target intestinal tract phytobacterium lactis strain

ActiveCN119081942AHigh insecticidal activityBiocideBacteriaBiotechnologyMicroorganism
The invention relates to a non-target intestinal lactobacillus strain capable of improving insecticidal activity of Cry protein and application of the non-target intestinal lactobacillus strain. The strain number of the lactobacillus lactis strain is R-8, the lactobacillus lactis strain is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC No.31544.
Owner:INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI

Lactobacillus marzei strains and uses thereof

The present invention relates to a novel Lactobacillus marzei CJST01 strain having excellent steviol glycoside transglycosylation activity, and a method for producing a steviol glycoside using the same. Compared with the known Lactobacillus margaritae DSM20444 strain capable of generating the steviol glycoside transglycosylation effect, the novel Lactobacillus margaritae CJST01 strain has excellent steviol glycoside transglycosylation activity, so that the enzyme reaction time in the production process is shortened. The steviol glycosides produced by using the strain have the advantage of a better taste quality or flavor than alpha-1, 4-linked steviol glycosides and rebaudioside M. In addition, the transglycosylated rebaudioside A produced by using the Lactobacillus margaritae CJST01 strain has a reduced foreign taste and flavor, and excellent solubility.
Owner:CJ CHEILJEDANG CORP

Lactic acid bacteria strain composition for improving chronic kidney disease and its application

The present invention belongs to the technical field of microbial preparations, and is particularly related to a lactic acid bacteria strain composition and its application for improving chronic kidney disease. The technical problem to be solved by the present invention is to provide a microbial composition, which has the effect of reducing uremic toxins and their precursors and slowing down renal tissue lesions to improve chronic kidney disease (chronic kidney disease, CKD) and improve renal function. The technical scheme of the present invention is a lactic acid bacteria strain pharmaceutical composition for improving chronic kidney disease, which includes a lactic acid bacteria strain mixture and a pharmaceutically acceptable carrier; the lactic acid bacteria strain mixture includes Lactobacillus acidophilus (Lactobacillus acidophilus) PCo-96, Lactobacillus casei (Lacticaseibacillus casei) ZE-2, Bifidobacterium longum subsp. infantis (Bifidobacterium longum subsp. infanttis) BR631 and Streptococcus salivarius subsp. thermophilus (Streptococcus salivarius subsp. thermophilus) Hot-06. The lactic acid bacteria strain composition of the present invention provides a new option for improving chronic kidney disease or maintaining renal function.
Owner:BIO RACE BIOTECH HANGZHOU CO LTD

A kühwein-like Lactobacillus strain and its application

The present invention discloses a kühwein-like Lactobacillus and its application, belonging to the field of microbial technology. Lactobacillus kefiranofaciens ) strain number 2503, deposited with the General Microbiology Center of the China National Center for Microbiological Culture Collection under the accession number CGMCC No. 33828. The kumiss-like Lactobacillus provided by the present invention has strong acid and bile salt tolerance, antioxidant and free radical scavenging properties, and can colonize the intestines, increasing the abundance of beneficial bacteria and reducing the abundance of pathogenic bacteria. It has excellent preventive and therapeutic effects on inflammatory bowel disease.
Owner:TIANJIN UNIV OF SCI & TECH

Novel lactobacillus strains

The present invention relates to novel strains of Lactobacillus genus having extended shelf life properties, i.e., capable of extending the shelf life of food products (e.g., fermented milk products) at room temperature without severely impairing the antimicrobial, antifungal and / or anti-yeast effect ability of said strains when added to such products. According to another aspect, the present invention relates to an antimicrobial, antifungal or anti-yeast composition. According to yet another aspect, the present invention relates to a food product. According to another aspect, the present invention relates to a method for manufacturing a food product. According to another aspect, the present invention relates to the use of Lactobacillus strains for providing antifungal, antimicrobial and / or anti-yeast effects, for example in fermented milk products.
Owner:DSM IP ASSETS BV

Spray-dried lactobacillus strains / cells and the use thereof against helicobacter pylori

The invention relates to spray-dried Lactobacillus strains and / or Lactobacillus cells (lactic acid bacteria) and to the uses thereof, in particular for pharmaceutical and / or dietary compositions for the treatment and prophylaxis of Helicobacter pylori infections in humans and animals.
Owner:NOVOZYMES AS

Composition containing lactobacillus strain and lactobacillus and use thereof

The present invention relates to a composition, which contains lactobacillus and lactobacillus, wherein the number of viable lactobacillus in the composition is not less than 1×10 6 CFU, the composition contains 1×10 6 ~1×10 10 The composition of the present invention can be used to treat and / or prevent vaginal infections such as bacterial vaginosis and aerobic bacterial vaginitis, and can be used in the pharmaceutical field.
Owner:CHENGDU BRILLIANT BIOPHARMACEUTICAL CO LTD +1

Compositions comprising lactobacillus strain

The present invention relates to Lactobacillus paracasei HH20 MXS_B2_71_3 strain DSM 34860 and / or Lactobacillus rhamnosus HH03 OB-Lb-0655 strain DSM 34859, in the form of viable cells and / or non-viable cells and / or cell fragments and / or as fermentation broth, or combinations thereof, for use as a medicament, preferably for use as a medicament in one or more human and / or animal subject; as well as oral care compositions, methods and kits comprising said species.
Owner:NOVOZYMES AS

Lactobacillus strain ls.1 and its use

The present application belongs to the field of microbial technology, and particularly relates to a lactobacillus LS.1 and application thereof. Lentilactobacillus sunkii The lactobacillus sunkii subsp. LS.1 is acid-resistant, can produce acid quickly, has high acid accumulation, and can inhibit the growth of spoilage bacteria, and is used for fermenting crystal leek, and shows excellent color protection, crispness preservation and flavor improvement effects. The crystal leek product fermented by adding the lactobacillus LS.1 has uniform and transparent white scales on the inside and outside, uniform color without blackening and darkening, and no biological membrane is produced; the pickled leek has pure and mellow flavor, no pungent and irritating smell, no peculiar smell, sweet taste is dominant, and sour and salty tastes are coordinated; the product crispness can be better ensured, the product shelf life quality can be ensured to be stable without swelling under the condition of not using preservatives, the product quality is comprehensively improved, and the fermentation process control is convenient and simple, and the scale industrialization technology popularization can be realized.
Owner:HONGHE HOPEN FOOD CO LTD +2

Skin-protective composition comprising a mixture of lactobacillus strains as active ingredient

The present invention relates to a skin-protecting composition having an excellent effect on the improvement of skin damage caused by fine dust, ultraviolet rays, harmful pathogenic bacteria, and dry environments.
Owner:ITS HANBUL CO LTD

A method for producing a liquor-type tobacco flavoring agent by combining enzymatic treatment with liquid fermentation

The application discloses a kind of enzyme processing combination liquid fermentation production brewing type tobacco flavor agent's method, comprising the following steps: S1, cut tobacco is mixed with sorghum powder, after adding distilled water obtains tobacco-sorghum liquid medium;S2, yeast strain is inoculated to YPD culture medium and is cultivated, obtains yeast bacterial liquid;And / or lactobacillus strain is inoculated to MRS culture medium and is cultivated, obtains lactobacillus bacterial liquid;S3, configuration enzyme preparation solution, enzyme includes one or more of amylase, flavourzyme and saccharifying enzyme;S4, enzyme preparation solution is added to tobacco-sorghum liquid culture medium;S5, the yeast bacterial liquid and / or lactobacillus bacterial liquid of S2 is inoculated to the culture medium of S4 and is cultivated, obtains fermentation liquid flavor medium;S6, fermentation liquid flavor medium is freeze-dried, obtains tobacco flavor agent.The brewing type flavor agent of the application is prepared based on microbial fermentation technology, process is simple, condition is mild, cost is low, green environmental protection, improve the economic benefit of low quality cigarette.
Owner:CHINA TOBACCO YUNNAN IND

Agent for ameliorating symptoms of female menopause

It is an object to provide a novel technology that can improve a female menopausal symptom. Provided is an agent for improving a female menopausal symptom, containing a lactobacillus strain that is Lactobacillus gasseri CP2305 strain (accession number: FERM BP-11331), a processed product of the lactobacillus strain, or an extract thereof.
Owner:ASAHI GRP HLDG LTD

Limosilactobacillus reuteri strain with high riboflavin production and uses thereof

ActiveUS12674188B2BiotechnologyMicrobiology
The present invention to the identification of a novel isolated bacterial strain, the Limosilactobacillus reuteri strain which is characterized by a naturally occurring overproduction of riboflavin (vitamin B2) compared to other known strains of lactobacilli. Said strain of the Limosilactobacillus species is deposited under accession number LMG P-32020. In a further aspect, also the uses of said L. reuteri strain are disclosed herein. In particular, the use of said strain in food and feed industry, human and veterinary health, large-scale vitamin production, cosmetics and consumer care products is disclosed.
Owner:UNIVERSITEIT ANTWERPEN